Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul-Joseph Aspuria

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cellular Signalling|July 9, 2004
The Rheb family of GTP-binding proteinsPaul-Joseph Aspuria, Fuyuhiko Tamanoi
Molecular Genetics and Genomics : MGG|January 26, 2008
The Tsc/Rheb signaling pathway controls basic amino acid uptake via the Cat1 permease in fission yeastPaul-Joseph Aspuria, Fuyuhiko Tamanoi
Cell Cycle (Georgetown, Tex.)|July 20, 2007
The TSC/Rheb/TOR signaling pathway in fission yeast and mammalian cells: temperature sensitive and constitutive active mutants of TORPaul-Joseph Aspuria, Tatsuhiro Sato, Fuyuhiko Tamanoi
Gynecologic Oncology|September 9, 2015
Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activationZhenqiu Liu, Jessica A Beach, Hasmik Agadjanian, et al.
Molecular Microbiology|November 3, 2005
Identification of novel single amino acid changes that result in hyperactivation of the unique GTPase, Rheb, in fission yeastJun Urano, Melissa J Comiso, Lea Guo, et al.
Oncotarget|September 17, 2016
FOXC2 augments tumor propagation and metastasis in osteosarcomaMaricel C Gozo, Dongyu Jia, Paul-Joseph Aspuria, et al.
Experimental Cell Research|May 8, 2020
HOXB13 controls cell state through super-enhancersPaul-Joseph Aspuria, Dong-Joo Cheon, Maricel C Gozo, et al.
Science Translational Medicine|December 22, 2021
An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphomaPaul-Joseph Aspuria, Sandro Vivona, Michele Bauer, et al.
Cancer Research|October 22, 2009
A role for BRCA1 in uterine leiomyosarcomaDeyin Xing, George Scangas, Mai Nitta, et al.
Oncotarget|January 6, 2015
Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETSBarbie Taylor-Harding, Paul-Joseph Aspuria, Hasmik Agadjanian, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cellular Signalling|July 9, 2004
The Rheb family of GTP-binding proteinsPaul-Joseph Aspuria, Fuyuhiko Tamanoi
Molecular Genetics and Genomics : MGG|January 26, 2008
The Tsc/Rheb signaling pathway controls basic amino acid uptake via the Cat1 permease in fission yeastPaul-Joseph Aspuria, Fuyuhiko Tamanoi
Cell Cycle (Georgetown, Tex.)|July 20, 2007
The TSC/Rheb/TOR signaling pathway in fission yeast and mammalian cells: temperature sensitive and constitutive active mutants of TORPaul-Joseph Aspuria, Tatsuhiro Sato, Fuyuhiko Tamanoi
Gynecologic Oncology|September 9, 2015
Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activationZhenqiu Liu, Jessica A Beach, Hasmik Agadjanian, et al.
Molecular Microbiology|November 3, 2005
Identification of novel single amino acid changes that result in hyperactivation of the unique GTPase, Rheb, in fission yeastJun Urano, Melissa J Comiso, Lea Guo, et al.
Oncotarget|September 17, 2016
FOXC2 augments tumor propagation and metastasis in osteosarcomaMaricel C Gozo, Dongyu Jia, Paul-Joseph Aspuria, et al.
Experimental Cell Research|May 8, 2020
HOXB13 controls cell state through super-enhancersPaul-Joseph Aspuria, Dong-Joo Cheon, Maricel C Gozo, et al.
Science Translational Medicine|December 22, 2021
An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphomaPaul-Joseph Aspuria, Sandro Vivona, Michele Bauer, et al.
Cancer Research|October 22, 2009
A role for BRCA1 in uterine leiomyosarcomaDeyin Xing, George Scangas, Mai Nitta, et al.
Oncotarget|January 6, 2015
Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETSBarbie Taylor-Harding, Paul-Joseph Aspuria, Hasmik Agadjanian, et al.
Pageof 2